William J Peters is CFO, EVP & TREASURER of Amphastar Pharmaceuticals, Inc.. Currently has a direct ownership of 94,103 shares of AMPH, which is worth approximately $4.15 Million. The most recent transaction as insider was on Nov 06, 2024, when has been sold 7,426 shares (Common Stock) at a price of $52.05 per share, resulting in proceeds of $386,523. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.1K
0% 3M change
7.16% 12M change
Total Value Held $4.15 Million

WILLIAM J PETERS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 06 2024
SELL
Open market or private sale
$386,523 $52.05 p/Share
7,426 Reduced 7.31%
94,103 Common Stock
Nov 06 2024
BUY
Exercise of conversion of derivative security
$96,760 $13.03 p/Share
7,426 Added 6.82%
101,529 Common Stock
Jul 31 2024
SELL
Open market or private sale
$454,772 $44.23 p/Share
10,282 Reduced 9.85%
94,103 Common Stock
Jul 31 2024
BUY
Exercise of conversion of derivative security
$208,004 $20.23 p/Share
10,282 Added 8.97%
104,385 Common Stock
Jun 27 2024
SELL
Open market or private sale
$147,687 $41.07 p/Share
3,596 Reduced 3.68%
94,103 Common Stock
May 19 2024
SELL
Payment of exercise price or tax liability
$16,826 $43.48 p/Share
387 Reduced 0.4%
97,268 Common Stock
Mar 17 2024
SELL
Payment of exercise price or tax liability
$183,177 $43.05 p/Share
4,255 Reduced 4.18%
97,655 Common Stock
Mar 16 2024
SELL
Payment of exercise price or tax liability
$219,770 $43.05 p/Share
5,105 Reduced 4.77%
101,910 Common Stock
Mar 15 2024
SELL
Payment of exercise price or tax liability
$98,369 $43.05 p/Share
2,285 Reduced 2.09%
107,015 Common Stock
Mar 06 2024
SELL
Open market or private sale
$854,024 $47.09 p/Share
18,136 Reduced 13.99%
111,490 Common Stock
Mar 06 2024
SELL
Payment of exercise price or tax liability
$101,418 $46.31 p/Share
2,190 Reduced 1.96%
109,300 Common Stock
Mar 06 2024
BUY
Exercise of conversion of derivative security
$99,998 $11.33 p/Share
8,826 Added 6.37%
129,626 Common Stock
Mar 04 2024
BUY
Grant, award, or other acquisition
-
19,440 Added 13.86%
120,800 Common Stock
Nov 14 2023
SELL
Open market or private sale
$3,297,262 $55.65 p/Share
59,250 Reduced 36.89%
101,360 Common Stock
Nov 14 2023
BUY
Exercise of conversion of derivative security
$985,327 $16.63 p/Share
59,250 Added 26.95%
160,610 Common Stock
Sep 06 2023
SELL
Open market or private sale
$3,158,636 $52.0 p/Share
60,743 Reduced 37.47%
101,360 Common Stock
Sep 06 2023
BUY
Exercise of conversion of derivative security
$998,920 $17.68 p/Share
56,500 Added 25.85%
162,103 Common Stock
Jun 15 2023
SELL
Open market or private sale
$1,872,525 $50.79 p/Share
36,868 Reduced 25.88%
105,603 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
$729,617 $19.79 p/Share
36,868 Added 20.56%
142,471 Common Stock
Jun 02 2023
SELL
Open market or private sale
$509,850 $46.35 p/Share
11,000 Reduced 9.43%
105,603 Common Stock
Jun 02 2023
BUY
Exercise of conversion of derivative security
$146,850 $13.35 p/Share
11,000 Added 8.62%
116,603 Common Stock
May 19 2023
SELL
Payment of exercise price or tax liability
$16,692 $44.16 p/Share
378 Reduced 0.36%
104,770 Common Stock
May 18 2023
SELL
Open market or private sale
$465,675 $44.35 p/Share
10,500 Reduced 9.08%
105,148 Common Stock
May 18 2023
BUY
Exercise of conversion of derivative security
$140,175 $13.35 p/Share
10,500 Added 8.32%
115,648 Common Stock
Apr 17 2023
SELL
Open market or private sale
$238,515 $42.35 p/Share
5,632 Reduced 5.08%
105,148 Common Stock
WJP

William J Peters

CFO, EVP & TREASURER
Rancho Cucamonga, CA

Track Institutional and Insider Activities on AMPH

Follow Amphastar Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPH shares.

Notify only if

Insider Trading

Get notified when an Amphastar Pharmaceuticals, Inc. insider buys or sells AMPH shares.

Notify only if

News

Receive news related to Amphastar Pharmaceuticals, Inc.

Track Activities on AMPH